CG

Charmaine Gittleson

Percheron Therapeutics Limited | Executive Chairman, Executive Director
Dr Gittleson has experience across healthcare, life sciences and governance, with a background spanning clinical practice and research, medical leadership, regulatory strategy, product development and board oversight. She is the former Chief Medical Officer of CSL. She is currently Chair of Percheron Therapeutics Ltd, and a Non-Executive Director of Imugene Limited and George Medicines Ltd.

Companies and Roles

Company
Title
Tenure
Since
PER
PER
Percheron Therapeutics Limited
  • Executive Chairman
  • Executive Director
5yrs, 5mthMar 2021
PNV
PNV
Polynovo Limited
  • Non-Executive Director
5mthApr 2026
IMU
IMU
Imugene Limited
  • Non-Executive Director
2mthJun 2026

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
IMU
IMU
Imugene Limited
30/06/260N/AN/AN/A
PNV
PNV
Polynovo Limited
01/04/260N/AN/AN/A
PER
PER
Percheron Therapeutics Limited
30/06/25N/A2,399,999N/AN/A
PAB
PAB
23/08/24N/AN/A8,000,000N/A
ANP
ANP
29/11/230733,3333,006,667N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
PER
PER
Percheron Therapeutics Limited
20/05/25
Issued
239,999$0.035$8,399Issue of options
PER
PER
Percheron Therapeutics Limited
31/12/24
Buy
1,666,666$0.009$14,999On-market trade
PER
PER
Percheron Therapeutics Limited
20/12/24
Expiry
6,667$0.007$46Options expired
PER
PER
Percheron Therapeutics Limited
29/11/23
Issued
3,000,000$0.060$180,000Issue of options
ANP
ANP
29/11/23
Issued
3,000,000$0.060$180,000Issue of options